Gamma Knife Market Size Worth $239.2 Million by 2025 | CAGR: 3.7%: Grand View Research, Inc.

Gamma Knife Market Size Worth $239.2 Million by 2025 | CAGR: 3.7%: Grand View Research, Inc.

PR Newswire

SAN FRANCISCO, September 12, 2017

SAN FRANCISCO, September 12, 2017 /PRNewswire/ --

The global gamma knife market is expected to reach USD 239.2 million by 2025, according to a new report by Grand View Research, Inc. Increasing prevalence of cancer, brain tumors, and other neurological diseases, rising adoption of these instruments in surgery centers, growing preference for Minimally Invasive Surgeries (MIS), and technological advancements in the device are amongst few factors expected to drive the market.

     (Logo: http://photos.prnewswire.com/prnh/20160524/371361LOGO )

Gamma knife therapy is used for treatment of various brain and neurological disorders such as brain tumors, brain metastases, epilepsy, and arteriovenous malformations. Demand for these instruments in surgery centers is growing due to their various advantages such as safety, micro precision, lack of postsurgical complications, and lack of incisions.

Technological advancements have improved precision in surgery. For instance, upgradation of Leksell Gamma Knife models U, B, C/4C, and Perfexion to Icon provided micro precision in surgery and boosted adoption of this device in surgery centers. According to reports published by Elekta AB, approximately 70,000 patients undergo gamma knife surgery each year. This number is expected to increase over the forecast period owing to rising prevalence of target diseases and increasing preference for MIS.

In addition, growing demand for MIS over open surgeries is one of the key factors responsible for increasing adoption of this therapy. Gamma knife treatment procedure results in fewer traumas and faster recovery as compared to open surgeries. It helps reduce hospital stays, thus ensuring economic viability and reduction in medical expenses. Lack of incisions and postsurgical complications are key factors responsible for boosting demand for minimally invasive surgeries.

Browse full research report with TOC on "Gamma Knife Market Analysis By Indication (Malignant Tumors, Benign Tumors, Vascular Disorders, Functional Disorders, Ocular Diseases), By Region, And Segment Forecasts, 2014 - 2025" at: http://www.grandviewresearch.com/industry-analysis/gamma-knife-market

Further key findings from the report suggest: 

Browse related reports by Grand View Research: 

Grand View Research has segmented the gamma knife market on the basis of indications and region: 

Read Our Blog By Grand View Research: http://www.grandviewresearch.com/blogs/healthcare

About Grand View Research 

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: +1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com

Web: www.grandviewresearch.com

Voltar noticias em Inglês